Abstract
2D SPR values are greater in breasts with higher glandular tissue composition, whereas 3D SPR values appear independent of breast composition. This work is funded by the National Cancer Institute of the National Institutes of Health grant RO1-CA096821, with partial support (JHP) from NIH T32-EB001040. MPT is the inventor of this CT technology, and is named as an inventor on the patent for this technology awarded to Duke University. If this technology becomes commercially successful, MPT and Duke could benefit financially.